Infections in patients with gynecological malignancies: Prevention and management

Shivani Singh, Rodger David MacArthur

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Infections in patients with gynecological malignancies are frequent and a major cause of death and prolonged hospitalization. The patient with cancer is a compromised host and has increased susceptibility to infections due to the tumor itself and also due to therapeutic modalities such as extensive surgical procedures, radiation, and cytotoxic chemotherapy. Infections related to chemotherapy per se are less pronounced than those seen in patients with leukemia, lymphoma, and bone marrow transplantation who have prolonged neutropenia ranging from 1 to 4 weeks. Neutropenia in gynecological malignancy patients lasts approximately for 3 days and therefore infections related to febrile neutropenia are limited. In fact, chemotherapy did not increase the risk of wound complications in this population despite efforts to begin chemotherapy as soon as possible postcytoreductive surgery in one analysis performed in 1992.

Original languageEnglish (US)
Title of host publicationChemotherapy for Gynecological Neoplasms
Subtitle of host publicationCurrent Therapy and Novel Approaches
PublisherCRC Press
Pages257-273
Number of pages17
ISBN (Electronic)9781420030990
ISBN (Print)9780824754181
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Drug Therapy
Infection
Neutropenia
Neoplasms
Febrile Neutropenia
Bone Marrow Transplantation
Cause of Death
Lymphoma
Leukemia
Hospitalization
Radiation
Wounds and Injuries
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Singh, S., & MacArthur, R. D. (2004). Infections in patients with gynecological malignancies: Prevention and management. In Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches (pp. 257-273). CRC Press.

Infections in patients with gynecological malignancies : Prevention and management. / Singh, Shivani; MacArthur, Rodger David.

Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches. CRC Press, 2004. p. 257-273.

Research output: Chapter in Book/Report/Conference proceedingChapter

Singh, S & MacArthur, RD 2004, Infections in patients with gynecological malignancies: Prevention and management. in Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches. CRC Press, pp. 257-273.
Singh S, MacArthur RD. Infections in patients with gynecological malignancies: Prevention and management. In Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches. CRC Press. 2004. p. 257-273
Singh, Shivani ; MacArthur, Rodger David. / Infections in patients with gynecological malignancies : Prevention and management. Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches. CRC Press, 2004. pp. 257-273
@inbook{b0adfd4283f246f1ad87a1461d2b8e89,
title = "Infections in patients with gynecological malignancies: Prevention and management",
abstract = "Infections in patients with gynecological malignancies are frequent and a major cause of death and prolonged hospitalization. The patient with cancer is a compromised host and has increased susceptibility to infections due to the tumor itself and also due to therapeutic modalities such as extensive surgical procedures, radiation, and cytotoxic chemotherapy. Infections related to chemotherapy per se are less pronounced than those seen in patients with leukemia, lymphoma, and bone marrow transplantation who have prolonged neutropenia ranging from 1 to 4 weeks. Neutropenia in gynecological malignancy patients lasts approximately for 3 days and therefore infections related to febrile neutropenia are limited. In fact, chemotherapy did not increase the risk of wound complications in this population despite efforts to begin chemotherapy as soon as possible postcytoreductive surgery in one analysis performed in 1992.",
author = "Shivani Singh and MacArthur, {Rodger David}",
year = "2004",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824754181",
pages = "257--273",
booktitle = "Chemotherapy for Gynecological Neoplasms",
publisher = "CRC Press",

}

TY - CHAP

T1 - Infections in patients with gynecological malignancies

T2 - Prevention and management

AU - Singh, Shivani

AU - MacArthur, Rodger David

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Infections in patients with gynecological malignancies are frequent and a major cause of death and prolonged hospitalization. The patient with cancer is a compromised host and has increased susceptibility to infections due to the tumor itself and also due to therapeutic modalities such as extensive surgical procedures, radiation, and cytotoxic chemotherapy. Infections related to chemotherapy per se are less pronounced than those seen in patients with leukemia, lymphoma, and bone marrow transplantation who have prolonged neutropenia ranging from 1 to 4 weeks. Neutropenia in gynecological malignancy patients lasts approximately for 3 days and therefore infections related to febrile neutropenia are limited. In fact, chemotherapy did not increase the risk of wound complications in this population despite efforts to begin chemotherapy as soon as possible postcytoreductive surgery in one analysis performed in 1992.

AB - Infections in patients with gynecological malignancies are frequent and a major cause of death and prolonged hospitalization. The patient with cancer is a compromised host and has increased susceptibility to infections due to the tumor itself and also due to therapeutic modalities such as extensive surgical procedures, radiation, and cytotoxic chemotherapy. Infections related to chemotherapy per se are less pronounced than those seen in patients with leukemia, lymphoma, and bone marrow transplantation who have prolonged neutropenia ranging from 1 to 4 weeks. Neutropenia in gynecological malignancy patients lasts approximately for 3 days and therefore infections related to febrile neutropenia are limited. In fact, chemotherapy did not increase the risk of wound complications in this population despite efforts to begin chemotherapy as soon as possible postcytoreductive surgery in one analysis performed in 1992.

UR - http://www.scopus.com/inward/record.url?scp=85056674264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056674264&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85056674264

SN - 9780824754181

SP - 257

EP - 273

BT - Chemotherapy for Gynecological Neoplasms

PB - CRC Press

ER -